Business Description
Lifeward Ltd
NAICS : 339112
SIC : 3845
ISIN : IL0011331076
Total Employee Number:
81Description
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.3 | |||||
Equity-to-Asset | 0.19 | |||||
Debt-to-Equity | 1.4 | |||||
Debt-to-EBITDA | -0.53 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -13.14 | |||||
Beneish M-Score | -3.93 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 36.8 | |||||
3-Year EBITDA Growth Rate | 17.5 | |||||
3-Year EPS without NRI Growth Rate | 17.4 | |||||
3-Year FCF Growth Rate | 15.6 | |||||
3-Year Book Growth Rate | -61.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 61.26 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 55.37 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 87.15 | |||||
9-Day RSI | 76.11 | |||||
14-Day RSI | 68.39 | |||||
3-1 Month Momentum % | 11.95 | |||||
6-1 Month Momentum % | 2.65 | |||||
12-1 Month Momentum % | -4.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.4 | |||||
Quick Ratio | 1.82 | |||||
Cash Ratio | 1.07 | |||||
Days Inventory | 184.32 | |||||
Days Sales Outstanding | 101.03 | |||||
Days Payable | 152.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -28.7 | |||||
Shareholder Yield % | -45.29 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 36.55 | |||||
Operating Margin % | -106.95 | |||||
Net Margin % | -123.66 | |||||
EBITDA Margin % | -79.54 | |||||
FCF Margin % | -71.73 | |||||
OCF Margin % | -71.73 | |||||
ROE % | -212 | |||||
ROA % | -95.77 | |||||
ROIC % | -149.76 | |||||
3-Year ROIIC % | 21.67 | |||||
ROC (Joel Greenblatt) % | -328.3 | |||||
ROCE % | -130.44 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.48 | |||||
PB Ratio | 3.54 | |||||
Price-to-Tangible-Book | 14.58 | |||||
EV-to-EBIT | -0.91 | |||||
EV-to-EBITDA | -1.2 | |||||
EV-to-Revenue | 0.95 | |||||
EV-to-Forward-Revenue | 0.55 | |||||
EV-to-FCF | -1.33 | |||||
Price-to-GF-Value | 0.58 | |||||
Price-to-Median-PS-Value | 0.16 | |||||
Earnings Yield (Greenblatt) % | -109.89 | |||||
FCF Yield % | -66.49 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LFWD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lifeward Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 20.923 | ||
| EPS (TTM) ($) | -19.66 | ||
| Beta | 0.0647 | ||
| 3-Year Sharpe Ratio | -0.91 | ||
| 3-Year Sortino Ratio | -1.06 | ||
| Volatility % | 30.12 | ||
| 14-Day RSI | 68.39 | ||
| 14-Day ATR ($) | 0.469862 | ||
| 20-Day SMA ($) | 7.113255 | ||
| 12-1 Month Momentum % | -4.86 | ||
| 52-Week Range ($) | 4.14 - 10.9848 | ||
| Shares Outstanding (Mil) | 2.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lifeward Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lifeward Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 08:30 | In 134 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 133 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-14 08:30 | In 43 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 42 days | ||
| General meeting for 2026 | 2026-07-31 10:00 | In 29 days | ||
| First quarter earnings conference call for 2026 | 2026-05-15 08:30 | 6.60 (+4.80%) | ||
| First quarter earnings results for 2026 | 2026-05-15 | 6.60 (+4.80%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-18 08:30 | 7.56 (+1.34%) | ||
| Annual report for 2025 | 2026-03-18 | 7.56 (+1.34%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-18 | 7.56 (+1.34%) |
Show
Entries
Lifeward Ltd Frequently Asked Questions
What is Lifeward Ltd(LFWD)'s stock price today?
The current price of LFWD is $8.02. The 52 week high of LFWD is $10.98 and 52 week low is $4.14.
When is next earnings date of Lifeward Ltd(LFWD)?
The next earnings date of Lifeward Ltd(LFWD) is 2026-08-14 Est..
Does Lifeward Ltd(LFWD) pay dividends? If so, how much?
Lifeward Ltd(LFWD) does not pay dividend.
Guru Commentaries on NAS:LFWD
No articles.
Press Release
Articles on Lifeward Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers